We are proud to launch the Melanoma Nano-Vaccine Campaign in partnership with Canadian Friends of Tel Aviv University.  The purpose of the Melanoma Nano-Vaccine Campaign is to support the acceleration of groundbreaking melanoma nano-vaccine research.

In 2019, Professor Satchi-Fainaro and her team developed a nano-vaccine that successfully prevented and treated melanoma in mice. Holding immense promise, the nano-vaccine approach could not only revolutionize the prevention and treatment of melanoma, but also serve as a foundation for the development of nano-vaccines for other cancers.

Starting now and through the end of February, all funds raised through the Melanoma Nano-Vaccine Campaign will be matched by DCMF (up to maximum of $25,000).

Donate now to double your impact: https://cftau.ca/melanomanano-vaccine/